Status:
COMPLETED
Kinesiophobia, Quality of Life, and Cognitive Functions in Fibromyalgia Syndrome
Lead Sponsor:
Bozyaka Training and Research Hospital
Conditions:
Fibromyalgia
Kinesiophobia
Eligibility:
FEMALE
18-45 years
Brief Summary
Although one of the most evidence-based treatment protocols is based on exercise strategies in patients with Fibromyalgia Syndrome, fear and avoidance of physical activity; named 'Kinesiophobia' may h...
Detailed Description
Cognitive dysfunction, including learning difficulties, memory, attention, and executive dysfunctions are frequent in fibromyalgia syndrome. Kinesiophobia is defined as fear and avoidance of physical ...
Eligibility Criteria
Inclusion
- Fibromyalgia Syndrome
Exclusion
- Education year \< 5
- Inflammatory rheumatic disease
- Malignancy
- Psychiatric disease
- Alcohol/substance addiction
- Central nervous system disease
- History of head trauma
- Chronic pain conditions other than Fibromyalgia Syndrome
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 25 2022
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04695288
Start Date
January 1 2021
End Date
July 25 2022
Last Update
August 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Health Sciences Izmir Bozyaka Training and Research Hospital
Izmir, Karabaglar, Turkey (Türkiye)